These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26374826)

  • 1. Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.
    Fedorova OV; Zernetkina VI; Shilova VY; Grigorova YN; Juhasz O; Wei W; Marshall CA; Lakatta EG; Bagrov AY
    Circ Cardiovasc Genet; 2015 Oct; 8(5):736-45. PubMed ID: 26374826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.
    Zhang Y; Wei W; Shilova V; Petrashevskaya NN; Zernetkina VI; Grigorova YN; Marshall CA; Fenner RC; Lehrmann E; Wood WH; Becker KG; Lakatta EG; Bagrov AY; Fedorova OV
    J Am Heart Assoc; 2019 Oct; 8(20):e012138. PubMed ID: 31576777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
    Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
    J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavage.
    Dmitrieva RI; Bagrov AY; Lalli E; Sassone-Corsi P; Stocco DM; Doris PA
    Hypertension; 2000 Sep; 36(3):442-8. PubMed ID: 10988279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats.
    Fedorova OV; Agalakova NI; Talan MI; Lakatta EG; Bagrov AY
    J Hypertens; 2005 Aug; 23(8):1515-23. PubMed ID: 16003178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.
    Grigorova YN; Juhasz O; Long JM; Zernetkina VI; Hall ML; Wei W; Morrell CH; Petrashevskaya N; Morrow A; LaNasa KH; Bagrov AY; Rapp PR; Lakatta EG; Fedorova OV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
    Hauck C; Frishman WH
    Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
    Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
    Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats.
    Bagrov AY; Agalakova NI; Kashkin VA; Fedorova OV
    Am J Hypertens; 2009 May; 22(5):559-63. PubMed ID: 19229192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.
    Haller ST; Yan Y; Drummond CA; Xie J; Tian J; Kennedy DJ; Shilova VY; Xie Z; Liu J; Cooper CJ; Malhotra D; Shapiro JI; Fedorova OV; Bagrov AY
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.